These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29324926)

  • 41. Lymph Node Assessment in Prostate Cancer: Evaluation of Iodine Quantification With Spectral Detector CT in Correlation to PSMA PET/CT.
    Lennartz S; Täger P; Zopfs D; Iuga AI; Reimer RP; Zäske C; Große Hokamp N; Maintz D; Heidenreich A; Drzezga A; Kobe C; Persigehl T
    Clin Nucl Med; 2021 Apr; 46(4):303-309. PubMed ID: 33443954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Comparative Study of
    Gupta M; Choudhury PS; Hazarika D; Rawal S
    World J Nucl Med; 2017; 16(3):186-191. PubMed ID: 28670175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate-specific membrane antigen expression in melanoma metastases.
    Snow H; Hazell S; Francis N; Mohammed K; O'Neill S; Davies E; Mansfield D; Messiou C; Hujairi N; Nicol D; Harrington K; Smith M
    J Cutan Pathol; 2020 Dec; 47(12):1115-1122. PubMed ID: 32529651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PSMA PET and Radionuclide Therapy in Prostate Cancer.
    Bouchelouche K; Turkbey B; Choyke PL
    Semin Nucl Med; 2016 Nov; 46(6):522-535. PubMed ID: 27825432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer.
    Ravi Kumar AS; Lawrentschuk N; Hofman MS
    Curr Opin Urol; 2020 Sep; 30(5):628-634. PubMed ID: 32701720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CT
    Liu FY; Sheng TW; Tseng JR; Yu KJ; Tsui KH; Pang ST; Wang LJ; Lin G
    Br J Radiol; 2022 Mar; 95(1131):20210728. PubMed ID: 34767482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of bone scintigraphy and
    Pyka T; Okamoto S; Dahlbender M; Tauber R; Retz M; Heck M; Tamaki N; Schwaiger M; Maurer T; Eiber M
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2114-2121. PubMed ID: 27290607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre.
    Haran C; McBean R; Parsons R; Wong D
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):495-499. PubMed ID: 30972933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management.
    Koerber SA; Stach G; Kratochwil C; Haefner MF; Rathke H; Herfarth K; Kopka K; Holland-Letz T; Choyke PL; Haberkorn U; Debus J; Giesel FL
    J Nucl Med; 2020 Jan; 61(1):46-50. PubMed ID: 31302638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer.
    Kuten J; Mabjeesh NJ; Lerman H; Levine C; Barnes S; Even-Sapir E
    Isr Med Assoc J; 2019 Feb; 21(2):100-104. PubMed ID: 30772960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
    Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraindividual Comparison of
    Kesch C; Vinsensia M; Radtke JP; Schlemmer HP; Heller M; Ellert E; Holland-Letz T; Duensing S; Grabe N; Afshar-Oromieh A; Wieczorek K; Schäfer M; Neels OC; Cardinale J; Kratochwil C; Hohenfellner M; Kopka K; Haberkorn U; Hadaschik BA; Giesel FL
    J Nucl Med; 2017 Nov; 58(11):1805-1810. PubMed ID: 28473595
    [No Abstract]   [Full Text] [Related]  

  • 54. Status of
    Tang Y; Ji X; Lin Q; Huang H; Zhu H; Huang X; Xie H; Chen W; Zhuang Y
    World J Urol; 2023 Apr; 41(4):1017-1024. PubMed ID: 36932282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases.
    Einspieler I; Tauber R; Maurer T; Schwaiger M; Eiber M
    Clin Nucl Med; 2016 May; 41(5):e261-2. PubMed ID: 26859205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salvage lymph node dissection in hormone-naïve men: How effective is surgery?
    Hanske J; Ostholt J; Roghmann F; Müller G; Braun K; Gomez B; von Landenberg N; von Bodman C; Palisaar RJ; Liermann D; Noldus J; Brock M
    Urol Oncol; 2019 Nov; 37(11):812.e17-812.e24. PubMed ID: 31327750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumour-capsule interface measured on 18F-DCFPyL PSMA positron emission tomography/CT imaging comparable to multi-parametric MRI in predicting extra-prostatic extension of prostate cancer at initial staging.
    Brauchli D; Singh D; Chabert C; Somasundaram A; Collie L
    J Med Imaging Radiat Oncol; 2020 Dec; 64(6):829-838. PubMed ID: 32715593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexpected significant findings non-related to prostate cancer identified using combined prostate-specific membrane antigen positron emission tomography/CT and diagnostic CT scan in primary staging for prostate cancer.
    McEwan L; McBean R; Yaxley J; Wong D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):318-323. PubMed ID: 30840361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical value of 18F-PSMA-1007 PET/MRI in primary staging of patients with intermediate- to high-risk prostate cancer.
    Ali I; Rezk M; Hamouda D; Talaat O; Omar Y; Abdel Tawab M; Nasr I
    Br J Radiol; 2024 Feb; 97(1155):622-631. PubMed ID: 38265254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis.
    Gossili F; Mogensen AW; Konnerup TC; Bouchelouche K; Alberts I; Afshar-Oromieh A; Zacho HD
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):281-294. PubMed ID: 37597010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.